Free Trial

Adaptive Biotechnologies (ADPT) Competitors

Adaptive Biotechnologies logo
$17.27 +0.16 (+0.94%)
Closing price 04:00 PM Eastern
Extended Trading
$17.50 +0.23 (+1.33%)
As of 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ADPT vs. TWST, TXG, VCYT, VRNA, RVMD, ABVX, RNA, CYTK, MRUS, and RYTM

Should you be buying Adaptive Biotechnologies stock or one of its competitors? The main competitors of Adaptive Biotechnologies include Twist Bioscience (TWST), 10x Genomics (TXG), Veracyte (VCYT), Verona Pharma PLC American Depositary Share (VRNA), Revolution Medicines (RVMD), Abivax (ABVX), Avidity Biosciences (RNA), Cytokinetics (CYTK), Merus (MRUS), and Rhythm Pharmaceuticals (RYTM). These companies are all part of the "medical" sector.

Adaptive Biotechnologies vs. Its Competitors

Adaptive Biotechnologies (NASDAQ:ADPT) and Twist Bioscience (NASDAQ:TWST) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, media sentiment, institutional ownership, earnings, valuation and profitability.

99.2% of Adaptive Biotechnologies shares are held by institutional investors. 6.4% of Adaptive Biotechnologies shares are held by insiders. Comparatively, 3.0% of Twist Bioscience shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Adaptive Biotechnologies has higher earnings, but lower revenue than Twist Bioscience. Twist Bioscience is trading at a lower price-to-earnings ratio than Adaptive Biotechnologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Adaptive Biotechnologies$178.96M14.69-$159.49M-$0.82-21.06
Twist Bioscience$312.97M5.93-$208.73M-$1.45-21.21

Adaptive Biotechnologies presently has a consensus target price of $14.11, suggesting a potential downside of 18.29%. Twist Bioscience has a consensus target price of $48.50, suggesting a potential upside of 57.72%. Given Twist Bioscience's higher probable upside, analysts clearly believe Twist Bioscience is more favorable than Adaptive Biotechnologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Adaptive Biotechnologies
1 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.70
Twist Bioscience
2 Sell rating(s)
1 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.58

Adaptive Biotechnologies has a beta of 2.06, meaning that its stock price is 106% more volatile than the S&P 500. Comparatively, Twist Bioscience has a beta of 2.38, meaning that its stock price is 138% more volatile than the S&P 500.

In the previous week, Twist Bioscience had 13 more articles in the media than Adaptive Biotechnologies. MarketBeat recorded 22 mentions for Twist Bioscience and 9 mentions for Adaptive Biotechnologies. Adaptive Biotechnologies' average media sentiment score of 0.41 beat Twist Bioscience's score of 0.31 indicating that Adaptive Biotechnologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Adaptive Biotechnologies
2 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Twist Bioscience
7 Very Positive mention(s)
3 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Twist Bioscience has a net margin of -23.51% compared to Adaptive Biotechnologies' net margin of -59.07%. Twist Bioscience's return on equity of -29.03% beat Adaptive Biotechnologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Adaptive Biotechnologies-59.07% -60.93% -23.03%
Twist Bioscience -23.51%-29.03%-21.77%

Summary

Twist Bioscience beats Adaptive Biotechnologies on 8 of the 15 factors compared between the two stocks.

Get Adaptive Biotechnologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for ADPT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ADPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ADPT vs. The Competition

MetricAdaptive BiotechnologiesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$2.61B$3.38B$6.13B$10.46B
Dividend YieldN/A2.30%5.73%4.78%
P/E RatioN/A23.0785.1527.20
Price / Sales14.69451.46575.41179.83
Price / CashN/A46.1137.3961.86
Price / Book12.6110.5012.396.65
Net Income-$159.49M-$52.47M$3.32B$276.79M
7 Day Performance10.35%-1.00%-0.24%-1.51%
1 Month Performance33.77%14.49%9.56%5.45%
1 Year Performance259.79%13.92%71.67%36.24%

Adaptive Biotechnologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ADPT
Adaptive Biotechnologies
2.7998 of 5 stars
$17.27
+0.9%
$14.11
-18.3%
+244.3%$2.61B$178.96M0.00790News Coverage
Analyst Forecast
TWST
Twist Bioscience
3.7793 of 5 stars
$30.14
-3.4%
$48.50
+60.9%
-30.8%$1.88B$312.97M-20.79990Trending News
Analyst Revision
TXG
10x Genomics
4.0587 of 5 stars
$11.60
+1.1%
$13.65
+17.7%
-25.3%$1.43B$610.78M-16.571,240Trending News
Analyst Forecast
Analyst Revision
VCYT
Veracyte
3.7884 of 5 stars
$34.09
-2.0%
$40.90
+20.0%
+2.1%$2.74B$445.76M103.31790News Coverage
VRNA
Verona Pharma PLC American Depositary Share
1.4419 of 5 stars
$106.91
flat
$109.00
+2.0%
N/A$9.21B$42.28M-107.9930Positive News
RVMD
Revolution Medicines
4.2597 of 5 stars
$48.75
+1.1%
$74.64
+53.1%
+1.2%$9.02B$11.58M-10.83250Analyst Forecast
Insider Trade
ABVX
Abivax
3.4651 of 5 stars
$95.63
+2.0%
$114.25
+19.5%
+908.5%$7.30BN/A0.0061Analyst Forecast
Short Interest ↓
Gap Up
RNA
Avidity Biosciences
2.5737 of 5 stars
$48.96
-1.6%
$68.32
+39.5%
+8.1%$7.26B$10.90M-13.75190
CYTK
Cytokinetics
3.8297 of 5 stars
$59.59
-0.7%
$76.64
+28.6%
+13.4%$7.18B$18.47M-11.68250Insider Trade
MRUS
Merus
1.5577 of 5 stars
$94.85
+0.5%
$93.12
-1.8%
+84.9%$7.14B$36.13M-17.2537Short Interest ↓
RYTM
Rhythm Pharmaceuticals
3.078 of 5 stars
$100.77
0.0%
$106.64
+5.8%
+116.9%$6.70B$130.13M-33.48140Analyst Forecast

Related Companies and Tools


This page (NASDAQ:ADPT) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners